This video is sponsored by the Duke Clinical Medical Series.
Topics include:
* Management of Stable Coronary Disease: Implications of the COURAGE Trial
* Study Population
* COURAGE Trial 1999 2004 Enrollment
* Intensity of Medical Therapy at 5 Yrs in COURAGE Trial
* Medical Therapy Group at 5 Yrs
* COURAGE Trial: Patients Did Better Than Expected
* COURAGE Trial
* Seattle Angina Questionnaire (Higher Scores Are Better)
* Protocol Issues in COURAGE Trial
* COURAGE Trial
The host, Peter Berger, MD, has indicated that he receives research/grant support from
Conor and Cardiokinetix and is a consultant for Cordis/Johnson & Johnson, Boston
Scientific, and Biogen. He also owns equity in Lumen, Inc.
The guest faculty, Cindy Grines, MD, has indicated that she receives research/grant
support from Aventis, Berlex, Cariovascular Research Foundation, Lilly, Takeda and serves
on an advisory board for CV Therapeutics, Inc.
|
|